Nebula Research & Development LLC Keros Therapeutics, Inc. Put Options Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
168Shares Held
27.5MCall Options Held
42.8KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$120 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$104 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$99 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$82.3 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.67B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...